Literature DB >> 81872

Lead concentration in skeletal muscle in amyotrophic lateral sclerosis patients and control subjects.

S Conradi, L O Ronnevi, O Vesterberg.   

Abstract

The concentration of lead in the vastus lateralis muscle was determined in patients with amyotrophic lateral sclerosis and control subjects by flameless atomic absorption spectrophotometry. No statistically significant differences were found between these groups, and in both the figures were of the same magnitude as those earlier reported for normal individuals. Increased plasma lead concentrations do not seem to cause a significant deposition of lead in skeletal muscle. Therefore, plasma rather than skeletal muscle is the more likely source if pathological amounts of lead enter the motoneurones via the retrograde axoplasmic flow in amyotrophic lateral sclerosis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 81872      PMCID: PMC493213          DOI: 10.1136/jnnp.41.11.1001

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  Lead in human tissues.

Authors:  S B Gross; E A Pfitzer; D W Yeager; R A Kehoe
Journal:  Toxicol Appl Pharmacol       Date:  1975-06       Impact factor: 4.219

2.  Abnormal trace metals in man: lead.

Authors:  H A SCHROEDER; J J BALASSA
Journal:  J Chronic Dis       Date:  1961-10

3.  Lead concentrations in human tissues.

Authors:  P S Barry; D B Mossman
Journal:  Br J Ind Med       Date:  1970-10

4.  Serum protein binding of lead in vitro in amyotrophic lateral sclerosis patients and controls.

Authors:  S Conradi; L O Ronnevi; H Stibler
Journal:  J Neurol Sci       Date:  1978-06       Impact factor: 3.181

5.  Lead content of neuromuscular tissue in amyotrophic lateral sclerosis: case report and other considerations.

Authors:  A Petkau; A Sawatzky; C R Hillier; J Hoogstraten
Journal:  Br J Ind Med       Date:  1974-10

6.  Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood.

Authors:  R D Broadwell; M W Brightman
Journal:  J Comp Neurol       Date:  1976-04-01       Impact factor: 3.215

7.  Capillary permeability in ALS, determined through transcapillary escape rate of 125I-albumin.

Authors:  S Conradi; L Kaijser; L O Ronnevi
Journal:  Acta Neurol Scand       Date:  1978-03       Impact factor: 3.209

8.  Comparison between the retrograde axonal transport of nerve growth factor and tetanus toxin in motor, sensory and adrenergic neurons.

Authors:  K Stöckel; M Schwab; H Thoenen
Journal:  Brain Res       Date:  1975-11-28       Impact factor: 3.252

9.  Kinetic analysis of lead metabolism in healthy humans.

Authors:  M B Rabinowitz; G W Wetherill; J D Kopple
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

10.  Heavy metals in normal Japanese tissues. Amounts of 15 heavy metals in 30 subjects.

Authors:  K Sumino; K Hayakawa; T Shibata; S Kitamura
Journal:  Arch Environ Health       Date:  1975-10
View more
  4 in total

Review 1.  Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era.

Authors:  Ximena Paez-Colasante; Claudia Figueroa-Romero; Stacey A Sakowski; Stephen A Goutman; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2015-04-21       Impact factor: 42.937

2.  Urinary excretion of lead and mercury after oral administration of meso-2,3-dimercaptosuccinic acid in patients with motor neurone disease.

Authors:  E S Louwerse; J P Buchet; M A Van Dijk; V J de Jong; R R Lauwerys
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

Review 3.  A meta-analysis of observational studies of the association between chronic occupational exposure to lead and amyotrophic lateral sclerosis.

Authors:  Ming-Dong Wang; James Gomes; Neil R Cashman; Julian Little; Daniel Krewski
Journal:  J Occup Environ Med       Date:  2014-12       Impact factor: 2.162

Review 4.  Environmental insults: critical triggers for amyotrophic lateral sclerosis.

Authors:  Bing Yu; Roger Pamphlett
Journal:  Transl Neurodegener       Date:  2017-06-16       Impact factor: 8.014

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.